Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Liquid vs Lyophilized Synagis in Premature Children
NCT00240929Phase 2Completed
- Sponsor
- MedImmune
- Start
- Sep 2002
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of palivizumab in respiratory syncytial virus infection (RSV), sponsored by MedImmune. Started Sep 2002; status: completed.
02
Drugs
palivizumab
03
Conditions
respiratory syncytial virus infection (RSV)
Beyond the preview
Go deeper on NCT00240929.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00240929.